Cargando…
Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness
In addition to their well-characterized roles in metabolism, lipids and lipoproteins have pleiotropic effects on the innate immune system. These undergo clinically relevant alterations during sepsis and acute inflammatory responses. High-density lipoprotein (HDL) plays an important role in regulatin...
Autores principales: | Barker, Grant, Leeuwenburgh, Christiaan, Brusko, Todd, Moldawer, Lyle, Reddy, Srinivasa T., Guirgis, Faheem W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071007/ https://www.ncbi.nlm.nih.gov/pubmed/33920038 http://dx.doi.org/10.3390/jcm10081693 |
Ejemplares similares
-
Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis
por: Guirgis, Faheem W., et al.
Publicado: (2021) -
A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes
por: Guirgis, Faheem W., et al.
Publicado: (2021) -
HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock
por: Guirgis, Faheem W., et al.
Publicado: (2018) -
LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock
por: Guirgis, Faheem W, et al.
Publicado: (2019) -
Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial
por: Guirgis, Faheem W., et al.
Publicado: (2020)